NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 09530449 持证商 MCM KLOSTERFRAU Vertr. GmbH 包装规格 100 St 剂型 Hartkapseln 需要医生开处方 nein Apothekenpflichtig nein 信息来源:https://www.besamex.de/produkt/hepar-sl-320-mg-hartkapseln-100-st-09530449.html
产品名称:ALVESCO 上市时间:02/16/2023NDA/ANDA/BLA:21658持证商:COVISNDC:70515-711-03,70515-711-04,70515-711-05,70515-712-03,70515-712-04,70515-712-05,70515-711-01,70515-712-01,70515-711-02,70515-712-02说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021658lbl.pdf批准信:https://www.accessdata.fda.gov/dr...
产品名称:MAGNESIUM SULFATE IN PLASTIC CONTAINER上市时间:02/15/2023NDA/ANDA/BLA:216597持证商:AMNEALNDC:70121-1719-9,70121-1720-9说明书:批准信:
产品名称:LIFITEGRAST上市时间:02/15/2023NDA/ANDA/BLA:215058持证商:INGENUS PHARMS LLCNDC:说明书:批准信:
产品名称:SAXAGLIPTIN上市时间:02/15/2023NDA/ANDA/BLA:205994持证商:GLENMARK PHARMSNDC:说明书:批准信:
产品名称:OSELTAMIVIR PHOSPHATE上市时间:02/14/2023NDA/ANDA/BLA:215538持证商:EPIC PHARMA LLCNDC:说明书:批准信:
产品名称:AFATINIB上市时间:02/14/2023NDA/ANDA/BLA:210804持证商:MSN PHARMACEUTICALS INCNDC:说明书:批准信:
产品名称:BEMUSTINE HYDROCHLORIDE上市时间:02/14/2023NDA/ANDA/BLA:205447持证商:BRECKENRIDGENDC:说明书:批准信:
产品名称:CARBOPROST TROMETHAMINE上市时间:02/13/2023NDA/ANDA/BLA:216882持证商:CAPLINNDC:65145-132-10,71839-137-10说明书:批准信:
产品名称:HYDRALAZINE HYDROCHLORIDE上市时间:02/13/2023NDA/ANDA/BLA:215147持证商:EUGIA PHARMANDC:55150-400-25说明书:批准信:
产品名称:BEMUSTINE HYDROCHLORIDE上市时间:02/13/2023NDA/ANDA/BLA:214739持证商:EUGIA PHARMA SPECLTSNDC:说明书:批准信: